Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

TRH stimulates human hair growth and extends the hair growth phase.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

The pituitary gland functions normally even after losing most SOX2+ stem cells.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Spironolactone may help reduce hair loss in androgenic alopecia.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

A young woman's Cronkhite-Canada syndrome improved on its own after she gave birth.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.